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Abstract
Background: Belly dancer’s dyskinesia is an extremely rare condition. It manifests as semicontinuous, slow, writhing,
sinuous abdominal wall movements that are bothersome to the patient. Management of this condition is extremely
difficult and challenging.
Methods: We describe four patients with belly dancer’s dyskinesia who were treated with Botulinum Toxin A (BTX)
injections under ultrasound guidance.
Results: All patients underwent the same BTX injection procedure using an aseptic technique under ultrasound
guidance. The patients responded well to the BTX injections after an unsatisfactory course of medical treatment.
The patients reported complete abolishment of abnormal abdominal movements with no side effects.
Conclusions: We report a cohort of patients with belly dancer dyskinesia treated successfully with BTX injections.
Ultrasound guidance for injections increases the accuracy and reduces the risk of the complications. BTX injection
under ultrasound guidance is a safe and effective treatment modality that should be employed as a first-line in the
management of patients with belly dancer’s dyskinesia.
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Background
Belly dancer’s dyskinesia is a rare disorder characterized
by the presence of repetitive semirhythmic multidirec-
tional displacements of the umbilicus associated with
writhing contortions of the anterior abdominal wall [1].
The condition was first reported in 1990 by Iliceto, who
observed such movements in five patients, one of whom
demonstrated diaphragmatic involvement as well (dia-
phragmatic flutter) [1]. Since then, only a few cases have
been reported in the literature with the majority of them
describing single cases only [2–15].
Due to the scarcity of reports in the literature, no con-
sensus has been established for the management of belly
dancer’s dyskinesia. Thus, the management of this con-
dition is challenging. Various treatment modalities have
been described in the management of this condition.
However, to date, there is no single treatment modality
that has proven to be effective and superior to others in
the management of such patients.
In this account, we describe a series of patients with
belly dancer’s dyskinesia and delineate the effectiveness
of ultrasound-guided Botulinum toxin A (BTX) injection
in the management of such patients.
Methods
This retrospective study aimed to report a series of belly
dancer’s dyskinesia patients and delineate the effective-
ness of ultrasound-guided BTX injection in the manage-
ment of such patients. Four patients with belly dancer’s
dyskinesia underwent the same diagnostic evaluations
and received the same BTX injection procedure under
ultrasound guidance as described below. The study was
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approved as part of the movement disorder program at
King Faisal Specialist Hospital and Research Centre and
Ibin Sina Hospital. Informed consent was obtained from
all patients described in this study.
Results
Case I
A 67-year-old man presented to our department with an
8-month-history of involuntary twisting and rolling move-
ment of abdominal muscles. The patient reported having
abnormal head turning movement for the past 20 years.
The head movement was involuntary and disappeared
during sleep. For the past 4 years he noticed abnormal
twisting movement of the right shoulder and elbow. The
head and right upper limb movements were not trouble-
some nor painful and thus he did not seek medical atten-
tion. Subsequently and for the past 8 months he started
experiencing abnormal involuntary twisting and roll-
ing movements of abdominal muscles. There was no pain
or discomfort accompanying the movements. The move-
ments were intermittent occurring throughout the day but
disappeared during sleep. He reported having difficulty
breathing and falling asleep due to the movements. He
had no family history of movement disorders and had not
been prescribed psychotropic or antidopaminergic medi-
cations. He denied having any surgery or trauma. Careful
psychiatric assessment showed no evidence of depression,
anxiety, and no history of neuroleptics use.
Neurological examination revealed normal higher men-
tal functions, cranial nerves, as well as motor and sensory
functions. Blepharospasm and laterocollis to right side
were noticed. Occasionally, periodic dystonic posturing
was observed in the right upper limb involving the shoul-
der and elbow.
In the supine position, involuntary writhing movements
of the abdominal wall muscles were seen in a wave fashion
that rolled across the abdomen due to asynchronous con-
tractions of the rectus abdominus muscle (Additional file 1:
video, segment 1). The movements did not show any vari-
ation in intensity or frequency in different positions nor
during inspiration and expiration.
All lab tests including copper, ceruloplasmin, thyroid
hormones, liver and renal functions, and blood smear were
unremarkable. Cranial and spinal magnetic resonance im-
aging (MRI) were normal. Fluoroscopic screening did not
show any diaphragmatic flutter.
Needle electromyographic (EMG) recordings of the orbi-
cularis oculi as well as neck, trunk, and abdominal muscles
showed abnormal motor unit potential discharges, some of
them tonic, varying over a wide range of frequency from
3–5 to 30–40 sec. In addition, sudden discharges from
groups of motor unit potentials was seen lasting from as
brief as 10–20 msec to over 3–5 sec. The discharges were
arrhythmical and asynchronous in separate muscles. They
were also repetitive but highly unpredictable (Fig. 1).
A diagnosis of multisegmetal dystonia with new-onset
belly dancer’s dyskinesia was established. The patient was
initially started on benztropine and clonazepam and the
doses were built-up gradually. Follow up 2 months later
did not show any improvement. Since the abdominal dys-
kinesia was the only bothersome condition for the patient
and due to drug failure, he was selected for bilateral rectus
Fig. 1 Needle electromyographic (EMG) recordings of the abdominal muscles showed abnormal motor unit potential discharges, some of them
tonic, varying over a wide range of frequency from 3–5 to 30–40 sec. In addition, sudden discharges from groups of motor unit potentials was
seen lasting from as brief as 10–20 msec to over 3–5 sec. The discharges were arrhythmical and asynchronous in separate muscles. They were
also repetitive but highly unpredictable
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abdominus injection with BTX under ultrasound guidance.
The procedure was performed using an aseptic technique
under ultrasound guidance to decrease the risk of compli-
cations such as penetration of the abdominal cavity, peri-
tonitis, or perforation of abdominal viscera [16]. A total of
300 units of BTX (Botox©, Allergan, Irvine, CA) was
injected in the rectus abdominus muscles bilaterally, in
which 50 units/site in a total of 6 sites were administered.
A follow up 2 weeks after the injection, tremendous im-
provement was reported by the patient. He was able to
perform his of daily living activities. On his 1 month fol-
low up, the patient reported complete disappearance of
the abnormal abdominal movements with no side effects.
His breathing difficulty and sleep pattern improved.
The effects of the injections lasted for 6 months, after
which the patient received another set of injections of
the same dose utilizing the same technique. The BTX ef-
fects in the second and third sessions lasted for about
8 months each. The patient was doing very well on his
last follow up visit with no reoccurrence of the move-
ments or adverse reactions to the injection.
Case II
A 61-year-old female presented to our department with
a seven-year-history of involuntary movements of the
abdominal wall. The movements were initially intermit-
tent. However, they gradually evolved over time to occur
more frequently. There was no pain but some discom-
fort was accompanying the movements. The movements
were not voluntarily suppressible and disappeared dur-
ing sleep. The rate and the amplitude of the involuntary
movements were increased by stress. Five years prior to
presentation, she underwent cholecystectomy, hysterec-
tomy, and oophorectomy. One year later she was diag-
nosed with depression and irritable bowel syndrome. She
was treated with lorazepam, fluoxetine, chlorodiazepoxide,
and clidinium bromide. The patient is a chronic smoker
with chronic obstructive pulmonary disease. She had no
family history of movement disorders.
Her neurological examination was unremarkable. Semi-
rhythmic writhing wavy movements involving abdominal
wall and paravertebral muscles producing displacement of
umbilicus were observed. These movements occurred ex-
clusively in the sitting and standing positions, and abolished
on lying on her sides and significantly decreased when lying
supine (Additional file 1: video, segment 2). The move-
ments did not show any variation in intensity or frequency
during respiration.
Laboratory, radiological, and fluoroscopic investigations
were normal similarly to case I. Abdominal ultrasound
depicted fatty liver. A diagnosis of belly dancer’s dyskinesia
was made and she was started on trihexylphenydil and clo-
nazepam, but without noticeable benefit.
Utilizing the same aseptic technique and under ultra-
sound guidance, a total of 240 units of BTX was injected
into the rectus abdominus muscles bilaterally, in which
40 units/site in a total of 6 sites were administered. The
patient reported marked improvement and she was able
to sit on the chair and walk independently 3 weeks after
the injections with no side effects. She has been on regu-
lar follow ups every 6 months, to which she received
BTX reinjection over a period of 48 months. On her last
follow up, the patient documented maintained thera-
peutic effects of the injections with no adverse events.
Case III
A 32-year-old male presented to us with abnormal move-
ments of the abdominal wall, which started 6 months ago.
The movements gradually progressed over time. They
were involuntary and intensified while sitting and walking.
The only position to decrease their frequency and inten-
sity was by lying down and lying on his left side. The
movements disappeared during sleep. They were not asso-
ciated with discomfort or pain. The movements did not
show any variation in intensity or frequency during respir-
ation. He did not undergo any surgery nor did he have
any history of trauma. He was not prescribed any medica-
tions, and family history was negative for movement disor-
ders. The patient had no history of psychiatric condition
or neuroleptics use.
His neurological examination was normal. Blood investi-
gations, abdominal ultrasound, fluoroscopy, and cranial and
spinal MRI were unremarkable.
The patient was diagnosed as a case of belly dancer’s
dyskinesia and underwent BTX injection under ultrasound
guidance using the same aseptic technique. 40 units/site of
BTX were injected, 3 sites on each side of the rectus abdo-
minus muscle, with a total of 240 units. The abdominal
dyskinetic movements started to gradually decrease over
time and they abolished completely 4 weeks after the in-
jections. However, on the third day after the injections, the
patient complained of abdominal distension, which im-
proved spontaneously over the following 7 days. He was
reviewed 10 months after the BTX injections, at which
time he did not complain of any abdominal movements.
Case IV
A 59-year-old mother of five children presented to our ser-
vice due to abnormal involuntary dyskinetic movements
predominantly involving the upper part of abdominal wall
above the umbilicus. The movements were associated with
abdominal discomfort; however, no pain or breathing diffi-
culties were experienced by the patient. These movements
persisted while sitting, standing, and lying down, but disap-
peared during sleep. The movements did not show any
variation in intensity or frequency during respiration. Seven
years ago, the patient underwent paraumbilical hernia
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surgery. Six months after the surgery she noticed involun-
tary abdominal dyskinesia movements involving the upper
part of her abdominal wall. She did not notice any move-
ments in the lower half of the abdominal wall. She had no
family history of movement disorders nor was she taking
any medications. Thorough psychiatric assessment showed
no evidence of psychiatric illness or neuroleptic use in the
patient.
Neurological examination, blood investigations, fluoros-
copy, as well as brain and spinal MRI were unremarkable.
She received a diagnosis of belly dancer’s dyskinesia and
underwent ultrasound-guided BTX injection using the
same aseptic technique. The patient received BTX injec-
tion at 4 sites, 2 sites on each side of the rectus abdominus
muscle above the umbilicus. A total of 200 units of BTX
was injected, in which 50 units/site were administered.
She responded very well to the injections with no side ef-
fects. She underwent reinjection 6 months after the first
session. The patient was doing very well on her last follow
up visit with no recurrence of the movements or adverse
reactions to the injection.
Discussion
Belly dancer’s dyskinesia was first reported by Iliceto et al.
in 1990 as semicontinuous, slow, writhing, sinuous ab-
dominal wall movements accompanied by abdominal dis-
comfort or pain [1]. Following the initial report only a few
cases have been reported in the literature in the form of
case reports [2–15]. To the best of our knowledge, this is
the third case series of patients with belly dancer’s dyskin-
esia in the literature following Iliceto’s [1] and Caviness’s
[3] reports of five and four patients, respectively.
The onset of belly dancer’s dyskinesia is usually gradual
and the movements are due to variable combination of con-
tractions of the rectus abdominis, oblique muscles, para-
spinal, and perineal muscles, as observed in our patients.
These movements tend to fluctuate with certain positions
and/or with respiration [1, 3–5]. Interestingly, none of our
patients showed fluctuations with respiration while two of
our patients reported increasing frequency and intensity of
the abnormal movements with certain position(s).
The pathophysiology of this condition is still unclear. It
has been postulated that these abnormal movements are
due to a dysfunction of inhibitory spinal interneurons or
structural reorganization of local neuronal circuits [1, 3].
In addition, it has been noted that these abnormal abdom-
inal movements arose after surgery [1, 3, 5–7], child birth
[1], trauma [1], dopaminergic and antidopaminergic treat-
ment [8, 9], central pontine and extra-pontine myelinoly-
sis [10], or as a result of spinal myoclonus [11, 12] and
spinal tumors [13]. In accordance with this observation,
two patients in our cohort developed the condition after
abdominal surgery, one of whom was also taking psycho-
tropic medications. Interestingly, the first case had these
movements as a part of his multisegmetal dystonic syn-
drome, as noted by the dystonic movements in his head,
right shoulder, and elbow. Trauma has been postulated to
alter the afferent signals from the site of impact to the
central nervous system, which may result in alterations in
the central processing of sensory information and the
emergence of an abdominal motor output [17, 18]. How-
ever, none of our patients had a trauma to the head or
periphery that could explain such movements.
The EMG features of the contractions consist of bursts
400–1000 msec in duration with superimposed jerky
movements, as reported by Iliceto et al [1]. In our first
case, the EMG demonstrated abnormal motor unit poten-
tial discharges, some of them tonic, varying over a wide
range of frequency from 3–5 to 30–40 sec. In addition,
sudden discharges from groups of motor unit potentials
were seen lasting from as brief as 10–20 msec to over 3–
5 sec. The discharges were arrhythmical and asynchron-
ous in separate muscles. They were also repetitive but
highly unpredictable (Fig. 1).
The management of belly dancer’s dyskinesia is extremely
challenging. Various medical and surgical treatment modal-
ities have been tried including benzodiazepines [3, 6, 12],
trihexyphenidyl [1, 3], valproate [1], carbamazepine [11],
transcutaneous electrical nerve stimulation [9], and deep
brain stimulation [4, 14]. However, due to the scarcity of
reports, no treatment modality has been proven to be su-
perior and effective in the management of this condition.
Therefore, the prognosis of belly dancer’s dyskinesia is
highly unpredictable.
Botulinum toxin is a neurotoxin produced by the anaer-
obic bacterium clostridium botulinum. It mediates its
effects by inhibition of acetylcholine release at the pre-
synaptic nerve endings of the motor endplates [19]. BTX
injection is a well-known modality in the management of
dystonia [20]. However, only one case report is present in
the literature that reported its efficacy in the management
of belly dancer’s dyskinesia [7]. The reported patient ini-
tially received a total of 90 units of BTX injection under
EMG guidance in the same 6 sites we used in our patients.
However, the patient in their report did not benefit from
the low dose injections and was given another injection
with a total dose of 240 units 3 months later, to which she
responded very well [7]. Therefore, we believe that it is es-
sential to address those patients with an initial large dose,
within the accepted safety window, to overcome and elim-
inate the abnormal movements, as clearly demonstrated in
our patients.
All our patients underwent the same procedure using
an aseptic technique under ultrasound guidance to de-
crease the risk of complications such as penetration of the
abdominal cavity, peritonitis, or perforation of abdominal
viscera [16]. Utilizing the ultrasound guidance for injec-
tions improves the accuracy and localization, and reduces
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the risk of complications. In our patients, only one patient
developed abdominal distention that gradually improved
over 7 days. Therefore, ultrasound-guidance is extremely
beneficial in such cases to enhance the effectiveness and
eliminate the risk of complications.
In our small series, all patients responded well to the
BTX injections after an unsatisfactory course of medical
treatment. The patients reported complete abolishment
of abnormal abdominal movements. In addition, the
duration of the favorable effects of the injections was
variable among our patients. In cases 1, 2, and 4, the pa-
tients required BTX re-injection every 6–8 months over
a follow-up period up to 48 months. The third case had
a surprisingly sustainable improvement at his 10 month
follow-up visit. All patients were happy with the results
of this treatment, which justified their compliance with
BTX reinjections.
Our study is limited by the small sample size, lack of
control and comparison groups, and the retrospective
nature of our observation. Moreover, BTX injections are
limited by the relatively short-term response and the
lack of standardized dosage for such cases.
Conclusions
BTX injections under ultrasound guidance is a safe and ef-
fective treatment modality that should be employed as a
first-line management in patients with belly dancer’s dys-
kinesia. Ultrasound guidance increases the accuracy of in-
jections and reduces the risk of complications. Our patients
tolerated the treatment very well and the abnormal
movements were completely abolished. Further studies
are needed to confirm the effectiveness of BTX injec-
tions on such patients.
Additional file
Additional file 1: Consent was obtained from the patients to be videoed
for publication and academic purposes. Segment 1: Case I note the high
frequency semirhythmic undulating movements directing upwards prior to
Botulinum Toxin A (BTX) injections. Three weeks after BTX injections note the
marked reduction of the amplitude and frequency of the dyskinetic
movements. Segment 2: Case II showing the severe wavy dyskinetic
movements in the sitting positions. The movements abolished when
lying to the side and significantly decreased when supine. Eight
weeks after BTX injections depicting the complete abolishment of the
dyskinetic movements. (MP4 67.8 mb)
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